CIK 0001280776 · Non-accelerated filer<br>Smaller reporting company
IMMUNIC, INC.
Sign in to watch- Ticker
- IMUX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562358443
- Phone
- (332) 255-9818
- Business address
- 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
- Former names
- VITAL THERAPIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-05 | Nash Duane Executive Chairman | Grant or award · Stock Option | +560,000 | 560,000 | ||
| 2025-06-05 | PHILLIPS BARCLAY A Director | Grant or award · Stock Option | +150,000 | 150,000 | ||
| 2025-06-05 | Muehler Andreas Chief Medical Officer | Grant or award · Stock Option | +595,000 | 595,000 | ||
| 2025-06-05 | Vitt Daniel CEO and Director | Grant or award · Stock Option | +1,535,000 | 1,535,000 | ||
| 2025-06-05 | Neermann Joerg Director | Purchase | +30,000 | $0.76 | $23K | 200,000 |
| 2025-06-04 | Vitt Daniel CEO and Director | Purchase | +15,000 | $0.77 | $12K | 29,000 |
| 2025-06-04 | Vitt Daniel CEO and Director | Purchase | +15,000 | $0.77 | $12K | 29,000 |
| 2025-06-04 | Neermann Joerg Director | Purchase | +70,000 | $0.77 | $54K | 170,000 |
| 2025-06-03 | Whaley Glenn Chief Financial Officer | Purchase | +45,000 | $0.71 | $32K | 95,510 |
| 2025-06-03 | Rudick Richard Alan Director | Purchase | +143,075 | $0.70 | $100K | 230,375 |
| 2025-05-30 | Whaley Glenn Chief Financial Officer | Grant or award | +25,000 | $0.56 | $14K | 50,510 |
| 2024-12-04 | Nash Duane Executive Chairman | Grant or award · Stock Option | +300,000 | 300,000 | ||
| 2024-12-04 | Nash Duane Executive Chairman | Grant or award · Stock Option | +300,000 | 300,000 | ||
| 2024-12-04 | Muehler Andreas Chief Medical Officer | Grant or award · Stock Option | +315,000 | 315,000 | ||
| 2024-12-04 | Tardio Jason President and COO | Grant or award · Stock Option | +157,500 | 157,500 | ||
| 2024-12-04 | Vitt Daniel CEO and Director | Grant or award · Stock Option | +820,000 | 820,000 | ||
| 2024-12-04 | Whaley Glenn Chief Financial Officer | Grant or award · Stock Option | +265,000 | 265,000 | ||
| 2024-11-12 | Rudick Richard Alan Director | Purchase | +87,300 | $1.15 | $100K | 87,300 |
| 2024-07-22 | Skerjanec Simona Director | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2024-07-22 | Skerjanec Simona Director | Grant or award · Stock Option | +50,000 | 50,000 |
Page 4 of 9 · 170 trades